Compare VKTX & HIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VKTX | HIW |
|---|---|---|
| Founded | 2012 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.5B |
| IPO Year | 2014 | 1995 |
| Metric | VKTX | HIW |
|---|---|---|
| Price | $34.86 | $31.22 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 7 |
| Target Price | ★ $95.86 | $27.57 |
| AVG Volume (30 Days) | ★ 1.6M | 906.2K |
| Earning Date | 04-29-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 8.43% |
| EPS Growth | N/A | ★ 54.26 |
| EPS | N/A | ★ 0.29 |
| Revenue | N/A | ★ $806,112,000.00 |
| Revenue This Year | N/A | $6.03 |
| Revenue Next Year | N/A | $3.58 |
| P/E Ratio | ★ N/A | $108.57 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $22.96 | $20.45 |
| 52 Week High | $43.15 | $35.44 |
| Indicator | VKTX | HIW |
|---|---|---|
| Relative Strength Index (RSI) | 49.73 | 50.64 |
| Support Level | $29.56 | $31.01 |
| Resistance Level | $36.69 | $32.18 |
| Average True Range (ATR) | 1.42 | 0.55 |
| MACD | 0.04 | -0.05 |
| Stochastic Oscillator | 47.70 | 73.14 |
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Highwoods Properties Inc is a fully integrated office REIT that owns, develops, acquires, leases, and manages office properties mainly in the best business districts of Atlanta, Charlotte, Dallas, Nashville, Orlando, Raleigh, Richmond, and Tampa. Its principal business is the operation, acquisition, and development of rental office properties, with no material inter-segment transactions. The Company evaluates performance by geographic location, and the operating results by geographic grouping are regularly reviewed by the chief operating decision maker. The core portfolio consists mainly of office properties in its key markets, with the majority of revenue derived from its Raleigh properties.